How would you measure the success of ConnectiveRx's Copay Assistance Program?

Introduction

Measuring the success of ConnectiveRx's Copay Assistance Program requires a comprehensive approach that considers multiple stakeholders and metrics. To effectively evaluate this program, I'll follow a structured framework covering core metrics, supporting indicators, and risk factors while considering all key stakeholders.

Step 1

Product Context

ConnectiveRx's Copay Assistance Program is a financial support initiative designed to help patients afford their prescribed medications by reducing out-of-pocket costs. Key stakeholders include patients, healthcare providers, pharmaceutical manufacturers, and insurance companies.

The user flow typically involves:

1. Patient receives a prescription
2. Healthcare provider or patient initiates copay assistance request
3. ConnectiveRx verifies eligibility and processes the request
4. Patient receives reduced copay at the pharmacy

This program aligns with ConnectiveRx's broader strategy of improving medication access and adherence. Compared to competitors, ConnectiveRx's program may offer wider coverage or a more streamlined process.

The product is in the growth stage, with opportunities for expansion and optimization.